Stock ICLR ICON PUBLIC LIMITED COMPANY
Add to a list
To use this feature you must be a member
Log inSign up

Calendar ICON Public Limited Company

Equities

ICLR

IE0005711209

Market Closed - Nasdaq
Other stock markets
 21:00:00 26/04/2024 BST 		5-day change 1st Jan Change
308.3 USD +2.74% Intraday chart for ICON Public Limited Company +6.97% +8.92%
04-26 UBS Adjusts ICON Price Target to $380 From $368, Maintains Buy Rating MT
04-25 Transcript : ICON Public Limited Company, Q1 2024 Earnings Call, Apr 25, 2024

Chart calendar ICON Public Limited Company

d757.o-8QYEffsS8glYEkrHjXGS6SANnOh5JR9pMSa21gDm8.0bx6OSuv2RYZ77Bn6zeyKAOjY56h_98krOZEJyUsYQz2pl43HbeHXVbA6g~c9ff6e9ad9b186d06a1cf3d595ec907a

Upcoming events on ICON Public Limited Company

23/07/2024 Q2 2024 Earnings Release (Projected)
22/10/2024 Q3 2024 Earnings Release (Projected)
18/02/2025 Q4 2024 Earnings Release (Projected)
22/04/2025 Q1 2025 Earnings Release (Projected)

Past events on ICON Public Limited Company

25/04/2024 13:00 Q1 2024 Earnings Call
24/04/2024 21:15 Q1 2024 Earnings Release
12/03/2024 18:05 Barclays Global Healthcare Conference
05/03/2024 16:10 TD Cowen Health Care Conference
22/02/2024 13:00 Q4 2023 Earnings Call
21/02/2024 21:15 Q4 2023 Earnings Release
10/01/2024 01:15 JPMorgan Healthcare Conference
02/12/2023 ASH Meeting
29/11/2023 17:30 Evercore ISI HealthCONx Conference
20/11/2023 OCT DACH Conference
14/11/2023 EBF Conference
14/11/2023 14:00 Jefferies London Healthcare Conference
12/11/2023 European Site Solutions Summit
11/11/2023 ISPOR EU Conference
29/10/2023 World Orphan Drug EU Congres
26/10/2023 13:00 Q3 2023 Earnings Call
25/10/2023 21:15 Q3 2023 Earnings Release
24/10/2023 Medical Innovation Forum
23/10/2023 OCT Nordics Conference
21/10/2023 AAPS PharmSci Conference

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		2 806
2 814
-0.29%		2 797
2 788
0.32%		5 481
5 494
-0.24%		7 741
7 744
-0.04%		8 120
8 146
-0.32%
8 640

EBITDA
Million USD		Released
Forecast
Spread 		495
494
0.18%		476
471
1.01%		970
964
0.67%		1 479
1 463
1.1%		1 694
1 675
1.16%
1 848

EBIT
Million USD		Released
Forecast
Spread 		433
433
0.15%		410
403
1.69%		655
863
-24.1%		1 373
1 367
0.43%		1 568
1 562
0.4%
1 713

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		427
426
0.2%		381
378
0.84%		197
399
-50.72%		568
627
-9.5%		624
642
-2.69%
975

Net income
Million USD		Released
Forecast
Spread 		374
374
-0.07%		332
330
0.82%		153
291
-47.4%		505
525
-3.68%		612
557
9.92%
839

EPS
USD		Released
Forecast
Spread 		6,79
6,89
-1.42%		6,15
6,17
-0.38%		2,25
3,19
-29.47%		6,13
6,78
-9.58%		7,40
6,79
9.04%
9,85

Announcement Date19/02/2024/02/2122/02/2222/02/2321/02/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD		Released
Forecast
Spread 		1 902
1 887
0.8%		1 935
1 928
0.38%		1 942
1 934
0.42%		1 962
1 965
-0.14%		1 979
1 980
-0.09%		2 020
2 017
0.15%		2 055
2 055
0.02%		2 066
2 093
-1.28%		2 090
2 088
0.09%
2 137


2 188


2 225


2 249


2 296

EBITDA
Million USD		Released
Forecast
Spread 		341
332
2.61%		354
349
1.54%		380
371
2.29%		405
396
2.36%		399
398
0.39%		414
412
0.62%		433
425
1.77%		448
438
2.24%		444
440
1.03%
453


468


482


488


494

EBIT
Million USD		Released
Forecast
Spread 		314
306
2.47%		329
314
4.55%		353
342
3.09%		378
370
2.13%		254
365
-30.45%		209
383
-45.3%		401
396
1.4%		414
409
1.45%		295
407
-27.59%
421


434


445


450


461

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		126
196
-35.71%		131
184
-28.72%		182
199
-8.32%		129
214
-39.78%		131
147
-10.61%		125
168
-25.35%		182
187
-2.59%		186
214
-12.78%		216
207
4.23%
227


251


275


275


279

Net income
Million USD		Released
Forecast
Spread 		112
165
-32.04%		116
139
-16.98%		160
155
3.43%		117
164
-28.49%		117
122
-4.23%		116
162
-28.69%		164
164
-0.32%		216
173
25.28%		187
169
11.13%
194


216


233


236


243

EPS
USD		Released
Forecast
Spread 		1,36
1,76
-22.87%		1,41
1,64
-13.95%		1,94
1,82
6.59%		1,42
2,15
-33.84%		1,41
1,45
-2.76%		1,40
1,67
-16.17%		1,97
1,98
-0.32%		2,60
2,11
23.22%		2,25
2,07
8.91%
2,36


2,59


2,79


2,83


2,93

Announcement Date27/04/2227/07/2202/11/2222/02/2326/04/2326/07/2325/10/2321/02/2424/04/24-----

Upcoming sector events for ICON Public Limited Company

28/04/2024 BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q1 2024 Earnings Release (Projected)
28/04/2024 SINO BIOLOGICAL,INC.: Q1 2024 Earnings Release
28/04/2024 JOINN LABORATORIES(CHINA)CO.,LTD.: Q1 2024 Earnings Release
28/04/2024 MORPHOSYS AG: Q1 2024 Earnings Release
29/04/2024 21:05 QIAGEN N.V.: Q1 2024 Earnings Release
29/04/2024 CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected)
30/04/2024 DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
30/04/2024 PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
30/04/2024 EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected)
30/04/2024 AZENTA, INC.: Q2 2024 Earnings Release (Projected)
More events

Past sector events for ICON Public Limited Company

Today GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release
Today GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release
26/04/2024 06:00 BB BIOTECH AG: Q1 2024 Earnings Release
25/04/2024 BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release
25/04/2024 PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release
25/04/2024 HINOVA PHARMACEUTICALS INC.: Q1 2024 Earnings Release (Projected)
25/04/2024 BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q4 2023 Earnings Release
25/04/2024 CHEMPARTNER PHARMATECH CO., LTD.: Q4 2023 Earnings Release
25/04/2024 12:00 MORPHIC HOLDING, INC.: Q1 2024 Earnings Release
25/04/2024 07:00 PURETECH HEALTH PLC: Q4 2023 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. ICLR Stock
  4. Calendar ICON Public Limited Company